286 related articles for article (PubMed ID: 26880392)
1. The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring.
Bronstone A; Graham C
J Diabetes Sci Technol; 2016 Jul; 10(4):905-13. PubMed ID: 26880392
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older.
Polonsky WH; Peters AL; Hessler D
J Diabetes Sci Technol; 2016 Jul; 10(4):892-7. PubMed ID: 27022095
[TBL] [Abstract][Full Text] [Related]
3. Real-Time Continuous Glucose Monitoring Facilitates Feelings of Safety in Older Adults With Type 1 Diabetes: A Qualitative Study.
Litchman ML; Allen NA
J Diabetes Sci Technol; 2017 Sep; 11(5):988-995. PubMed ID: 28376647
[TBL] [Abstract][Full Text] [Related]
4. Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with Type 1 diabetes.
Murphy HR; Feig DS; Sanchez JJ; de Portu S; Sale A;
Diabet Med; 2019 Dec; 36(12):1652-1658. PubMed ID: 31162713
[TBL] [Abstract][Full Text] [Related]
5. The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus.
Vigersky RA
J Diabetes Sci Technol; 2015 Mar; 9(2):320-30. PubMed ID: 25555391
[TBL] [Abstract][Full Text] [Related]
6. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain.
Conget I; Martín-Vaquero P; Roze S; Elías I; Pineda C; Álvarez M; Delbaere A; Ampudia-Blasco FJ
Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(7):380-386. PubMed ID: 29789227
[TBL] [Abstract][Full Text] [Related]
8. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
Hellmund R; Weitgasser R; Blissett D
Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
[TBL] [Abstract][Full Text] [Related]
9. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.
Willis WD; Diago-Cabezudo JI; Madec-Hily A; Aslam A
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):123-30. PubMed ID: 23402452
[TBL] [Abstract][Full Text] [Related]
10. Use of a Smartphone Application to Reduce Hypoglycemia in Type 1 Diabetes: A Pilot Study.
Feuerstein-Simon C; Bzdick S; Padmanabhuni A; Bains P; Roe C; Weinstock RS
J Diabetes Sci Technol; 2018 Nov; 12(6):1192-1199. PubMed ID: 29291641
[TBL] [Abstract][Full Text] [Related]
11. Determining clinical and psychological benefits and barriers with continuous glucose monitoring therapy.
Halford J; Harris C
Diabetes Technol Ther; 2010 Mar; 12(3):201-5. PubMed ID: 20151770
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool.
Hoskins N; Tikkanen CK; Pedersen-Bjergaard U
J Med Econ; 2017 Apr; 20(4):363-370. PubMed ID: 27926814
[TBL] [Abstract][Full Text] [Related]
13. The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes.
Fonda SJ; Graham C; Munakata J; Powers JM; Price D; Vigersky RA
J Diabetes Sci Technol; 2016 Jul; 10(4):898-904. PubMed ID: 26843480
[TBL] [Abstract][Full Text] [Related]
14. Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study.
Riddell MC; Milliken J
Diabetes Technol Ther; 2011 Aug; 13(8):819-25. PubMed ID: 21599515
[TBL] [Abstract][Full Text] [Related]
15. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D
J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183
[TBL] [Abstract][Full Text] [Related]
16. Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia.
Mahmoudi Z; Jensen MH; Dencker Johansen M; Christensen TF; Tarnow L; Christiansen JS; Hejlesen O
Diabetes Technol Ther; 2014 Oct; 16(10):667-78. PubMed ID: 24918271
[TBL] [Abstract][Full Text] [Related]
17. The burden of severe hypoglycemia in type 1 diabetes.
Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J
Curr Med Res Opin; 2018 Jan; 34(1):171-177. PubMed ID: 29019269
[TBL] [Abstract][Full Text] [Related]
18. Potential cost savings in the United States from a reduction in sensor-detected severe hypoglycemia among users of the InPen smart insulin pen system.
Chien A; Thanasekaran S; Gaetano A; Im G; Wherry K; MacLeod J; Vigersky RA
J Manag Care Spec Pharm; 2023 Mar; 29(3):285-292. PubMed ID: 36692907
[No Abstract] [Full Text] [Related]
19. Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year.
Chamberlain JJ; Dopita D; Gilgen E; Neuman A
J Diabetes Sci Technol; 2015 Sep; 10(2):383-8. PubMed ID: 26353781
[TBL] [Abstract][Full Text] [Related]
20. Cost and co-morbidities associated with hypoglycemic inpatients in Belgium.
Chevalier P; Vandebrouck T; De Keyzer D; Mertens A; Lamotte M
J Med Econ; 2016; 19(1):44-52. PubMed ID: 26428944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
